Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2026-03-06 @ 6:24 PM
Study NCT ID:
NCT01531894
Status:
COMPLETED
Last Update Posted:
2019-07-09
First Post:
2012-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Continuation Study of the Oral AKT Inhibitor GSK2110183
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02-08
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06-20
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-09
First Submit QC Date:
None
Study First Post Date:
2012-02-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-20
Results First Submit QC Date:
None
Results First Post Date:
2019-07-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-20
Last Update Post Date:
2019-07-09
Last Update Post Date Type:
ACTUAL